Kristen Stants serves as Executive at Magenta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Kristen Stants has executed 4 insider transactions totaling $38.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 30, 2022 involved receiving (via award) 3,000 shares valued at $2.8K.
Kristen Stants currently holds 20,264 shares of Magenta Therapeutics, Inc. (MGTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristen Stants has been a net seller of MGTA stock. They have purchased $0 and sold $38.6K worth of shares.
Kristen Stants's most recent insider trade was on Nov 30, 2022, when they sold 3,000 shares at $0.94 per share.
Get notified when new Form 4 filings are submitted
| $0.99 |
| Discretionary |
| Sep 16, 2021 | MGTA | $38.6K | Sale | 5,736 | $6.73 | Discretionary |
| Sep 14, 2021 | MGTA | $0 | Award | 20,000 | $N/A | Discretionary |